SAN DIEGO--(BUSINESS WIRE)--May 2, 2006--DexCom, Inc. (Nasdaq:DXCM - News) announced that the underwriters of its follow-on offering of common stock, which priced on April 26, 2006, have exercised their option to purchase an additional 717,375 shares of common stock from DexCom to cover over-allotments. DexCom granted the underwriters a 30-day over-allotment option to purchase up to 717,375 shares of common stock at the public offering price, less the underwriting discount. Net proceeds to DexCom from the exercise of the over-allotment option will be approximately $16.2 million.
